8-K: Mativ Announces Mixed Fourth Quarter and Full Year 2024 Results, Cites Progress in Turnaround Efforts
Earnings Release
Mativ Holdings, Inc. reports a slight increase in Q4 sales and improved GAAP income, but adjusted EBITDA declined, while full-year results show a decrease in sales but an increase in adjusted EBITDA.
Summary
- Mativ Holdings, Inc. reported its earnings results for the three months and year ended December 31, 2024.
- Q4 2024 sales increased 1.4% year over year to $458.6 million, with a 4.3% increase on an organic basis.
- GAAP income for Q4 2024 was $1.5 million, an improvement of $15.1 million compared to the prior year's loss of $13.6 million.
- Adjusted EBITDA for Q4 2024 was $44.8 million, down 10% versus the prior year.
- Full year 2024 sales decreased 2.2% year over year to $1,981.1 million, with a 1.0% decrease on an organic basis.
- GAAP loss for the full year was $48.7 million.
- Adjusted EBITDA for the full year was $218.0 million, up 2% versus the prior year.
- The company's debt matures on a staggered basis between 2027 and 2029.
- The company announced a quarterly cash dividend of $0.10 per share payable on March 28, 2025.
- The Filtration & Advanced Materials (FAM) segment saw sales decrease by 7.8% in Q4 2024 to $167.8 million.
- The Sustainable & Adhesive Solutions (SAS) segment sales increased by 7.5% in Q4 2024 to $290.8 million, with a 12.8% increase on an organic basis.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While sales were down for the full year and adjusted EBITDA was down in Q4, there were improvements in GAAP income and positive momentum in the SAS segment. Management's comments suggest confidence in future performance.
Positives
- GAAP income improved significantly in Q4 2024 compared to the prior year.
- Adjusted EBITDA increased for the full year 2024.
- SAS segment experienced strong organic revenue growth of almost 13% and adjusted EBITDA increased approximately 8% in Q4.
- Optical and medical films revenues were up almost 30% in Q4.
- The company is focused on high profit and cash accretive activities including pricing actions, cost reduction initiatives, and a stronger sales pipeline.
- The company redeemed the 2026 senior unsecured notes and issued new notes extending the debt maturity profile.
Negatives
- Adjusted EBITDA decreased in Q4 2024 compared to the prior year.
- Full year 2024 sales decreased compared to the prior year.
- FAM segment sales decreased by 7.8% in Q4 2024.
- The company reported a GAAP loss for the full year 2024.
- Advanced Films category faced challenges, particularly in paint protection films.
Risks
- Challenges in the Advanced Films category could continue to impact future performance.
- The company faces risks associated with strategic growth initiatives, acquisitions, and dispositions.
- Adverse changes in end-market sectors could impact key customers.
- Supply chain disruptions and increases in operating costs due to inflation could negatively affect the company.
- The company is exposed to risks related to international conflicts and disputes, such as the Russia-Ukraine conflict and the war between Israel and Hamas.
- The company faces risks associated with compliance with the FCPA and other anti-corruption laws.
Future Outlook
As Mativ enters 2025, they are focused on the highest profit and cash accretive activities including announced pricing actions, incremental manufacturing and overhead cost reduction initiatives, and a stronger sales pipeline, with confidence in their team and efforts to position Mativ for 2025 and beyond.
Management Comments
- Chief Executive Officer Julie Schertell commented, 'Our consolidated performance for Q4 was as expected.'
- 'We delivered strong Q4 results in our SAS segment with organic revenue growth of almost 13% and adjusted EBITDA increasing approximately 8%.'
- 'Our turnaround activities are well underway, and we are realizing improved cost, quality, lead time, and order delivery.'
Industry Context
Mativ operates in the specialty materials industry, serving diverse sectors such as filtration, advanced materials, and adhesive solutions; the results reflect a mixed performance across these sectors, with some facing challenges while others show growth.
Comparison to Industry Standards
- It's difficult to provide a precise comparison without knowing Mativ's specific competitors in each segment.
- However, companies like Ahlstrom-Munksjo (filtration media), Avery Dennison (adhesive solutions), and 3M (advanced materials) could be considered benchmarks.
- Mativ's adjusted EBITDA margin of 11.0% for the full year is within a reasonable range for specialty materials companies, but further analysis would be needed to determine if it's above or below average.
- The organic growth rate of -1.0% for the full year is below the average growth rate for the specialty materials industry, which is estimated to be around 3-5%.
Stakeholder Impact
- Shareholders will receive a quarterly cash dividend of $0.10 per share.
- Employees may be affected by organizational realignment and cost reduction initiatives.
- Customers may benefit from improved cost, quality, lead time, and order delivery as a result of turnaround activities.
Next Steps
- The company will hold a conference call to review fourth quarter 2024 results with investors and analysts on February 20, 2024.
Key Dates
| Date | Description |
|---|---|
| November 30, 2023 | Mativ completed the sale of its Engineered Papers business. |
| May 8, 2024 | The Company previously also filed a separate Form 8-K on May 8, 2024, which includes comparable financial statements for all fiscal quarters of 2023 revised to align with the new segment reporting structure. |
| October 7, 2024 | The Company redeemed the 2026 senior unsecured notes. |
| October 1, 2029 | Senior unsecured notes due. |
| February 19, 2025 | Mativ announced its next quarterly cash dividend and released Q4 2024 results. |
| March 14, 2025 | Stockholders of record date for the quarterly cash dividend. |
| March 28, 2025 | Payment date for the quarterly cash dividend. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.